NCT07184996 - An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis | Biotech Hunter

Enrollment

980

Participants

Timeline

Start Date

October 8, 2025

Primary Completion Date

May 9, 2028

Study Completion Date

May 9, 2028

Conditions

Ulcerative Colitis

Interventions

DRUG

Duvakitug

Pharmaceutical form:Solution for Injection-Route of administration:SC injection

DRUG

Placebo

Pharmaceutical form:Solution for injection-Route of administration:SC injection

Trial Locations (2)

RECRUITING

Precision Clinical Research-Site Number: 8400059, Coral Springs

RECRUITING

Correa Research Center-Site Number: 8400010, Miami